Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,910 | 132,418 | 105,635 | 87,622 | 125,332 |
| Marketable Securities | 30,216 | 98,509 | 196,578 | 281,289 | 330,454 |
| Receivables | 44,392 | 27,663 | 24,024 | 32,604 | 26,644 |
| Inventories | 33,431 | 33,233 | 33,209 | 27,723 | 23,943 |
| TOTAL | $336,091 | $368,835 | $435,915 | $514,577 | $574,250 |
| Non-Current Assets | |||||
| PPE Net | 60,523 | 61,908 | 63,563 | 66,851 | 66,467 |
| Intangibles | 18,532 | 18,976 | 19,809 | 20,283 | 12,933 |
| Other Non-Current Assets | 78,080 | 77,346 | 69,781 | 60,236 | 67,331 |
| TOTAL | $157,135 | $158,230 | $153,153 | $147,370 | $146,731 |
| Total Assets | $493,226 | $527,065 | $589,068 | $661,947 | $720,981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,366 | 1,872 | 3,083 | 10,967 | 5,408 |
| Accrued Expenses | 48,735 | 46,766 | 55,792 | 52,264 | 51,366 |
| Other current liabilities | 12,900 | 11,900 | 10,000 | 7,400 | 6,000 |
| TOTAL | $68,790 | $63,599 | $73,440 | $83,071 | $68,151 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 7,612 | 2,100 |
| Other Non-Current Liabilities | 271,874 | 354,640 | 270,677 | 313,424 | 306,366 |
| TOTAL | $349,597 | $354,640 | $337,499 | $313,424 | $306,366 |
| Total Liabilities | $418,387 | $418,239 | $410,939 | $396,495 | $374,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 266,163 | 266,156 | 266,143 | 266,143 | 266,141 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,497,461 | -1,458,350 | -1,386,752 | -1,296,420 | -1,217,302 |
| Other shareholders' equity | -5,983 | -6,509 | -5,238 | -4,802 | 980 |
| TOTAL | $74,839 | $108,826 | $178,129 | $265,452 | $346,464 |
| Total Liabilities And Equity | $493,226 | $527,065 | $589,068 | $661,947 | $720,981 |